Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Exeevo
AddedFeb 15, 2024
UpdatedJun 18, 2026
Exeevo

Exeevo

Series B

Exeevo: Global leader in CRM for life sciences, unifying sales, marketing, and patient experiences.

HQ
New York City, NY, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Exeevo, a global leader in customer relationship management (CRM) for the life sciences industry, focuses on unifying sales, marketing, and patient experiences. Their core mission is to enhance customer engagement through their omnichannel platform, which synchronizes touchpoints across various customer interactions. Exeevo offers AI-powered solutions like Omnipresence Copilot and Omnicare, designed to empower commercial, marketing, and medical teams with contextual insights and personalized patient engagement. The company primarily targets life sciences organizations looking to optimize their customer and patient experiences.

Notable affiliations include a strategic alliance with Microsoft, which has bolstered Exeevo’s technological capabilities. One of their key achievements is the development of Sanofi's OneCRM platform, positioning them as an innovative leader in digital-first customer experience solutions. Exeevo's impact is evident in its ability to deliver outstanding customer experiences across diverse markets, including China, through trusted AI life sciences cloud solutions.

Exeevo - Similar Companies

Xeno logo

Xeno

xeno.in

Convexa logo

Convexa

convexa.ai

Evoxis logo

Evoxis

Expirenza logo

Expirenza

expirenza.com

Exxo logo

Exxo

Power-Crm logo

Power-Crm

power-crm.net

smarteeva logo

smarteeva

smarteeva.com

Courier Health logo

Courier Health

courierhealth.com

Aiconex logo

Aiconex

OnEx Medical logo

OnEx Medical

medicalonex.com

Loyal logo

Loyal

loyalhealth.com

Xsell Technologies logo

Xsell Technologies

Exepron logo

Exepron

exepron.com

Tact.ai logo

Tact.ai

tact.ai

Optimove logo

Optimove

optimove.com

Exeevo - Quick Facts

Who are Exeevo's competitors?

Companies similar to Exeevo include Xeno, Convexa, Evoxis and Expirenza.

When was Exeevo founded?

Exeevo was founded in 2017.

Where is Exeevo's headquarters located?

Exeevo's headquarters is located in New York City, NY, US.

When was Exeevo's last funding round?

Exeevo's most recent funding round was for $20M (USD) in January 2020.

How much has Exeevo raised to-date?

As of Jan 9, 2020, Exeevo has raised a total of $20M (USD).

How many employees does Exeevo have?

Exeevo has 130 employees as of Feb 4, 2024.

Exeevo - Classification

Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • CRM
  • Patient Engagement
Tags
  • Cloud
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software